# Executive Assistant, supporting Chief Financial Officer at Olema Oncology

> United States · Director+ · Other · open. Source: https://alderhq.app/jobs/greenhouse%3Aolema%3A6147547004 (read 2026-11-12).

## Facts (observed)

- Company: [Olema Oncology](https://alderhq.app/companies/olema-oncology)
- Location text: San Francisco, California; Owens / SF
- Where it can be done from (inferred): United States (evidence: "Location: San Francisco, California; Owens / SF")
- Posted: 2026-08-24 (80 days ago)
- First seen by alder: 2026-11-07 · last verified: 2026-11-07
- Reposted: 0 times · edited: 0 times
- Apply on the employer's site: https://job-boards.greenhouse.io/olema/jobs/6147547004

## Pay and sponsorship

- Posted pay: not posted
- Market band for similar posted roles (SF Bay Area, n 1105): p25 $210k, median $250k, p75 $289k

## Description (the employer's text)

Olema Oncology is a clinical-stage biopharmaceutical company committed to transforming the standard of care and improving outcomes for patients living with breast cancer and beyond. With our transformation into a fully integrated oncology company well underway, it’s an exciting time to be part of Team Olema.

Our lead product candidate, palazestrant, is a novel, orally available complete estrogen receptor antagonist (CERAN) and selective estrogen receptor degrader (SERD) currently in two pivotal Phase 3 clinical trials. We expect top-line data from OPERA-01, our ongoing Phase 3 trial of palazestrant as a monotherapy in patients with second- or third-line ER+/HER2- metastatic breast cancer (MBC), in Q1 2027 which, if positive, could lead to our first potential approval and commercial launch in 2028. OPERA-02, our Phase 3 trial of palazestrant in combination with ribociblib in patients with frontline ER+/HER2- MBC, is enrolling patients. Together with its mechanism of action, pharmacokinetic properties, and the potential to demonstrate activity in both ESR1 wild-type and mutant tumors, palazestrant could transform the metastatic breast cancer treatment paradigm and provide access to a $15 billion global market opportunity.

Our follow-on product candidate, OP-3136, is a potent KAT6 inhibitor with the potential to generate further value and meaningfully impact the metastatic breast cancer treatment landscape – particularly in combination with palazestrant. We recently presented encouraging Phase 1 monotherapy data from this program across multiple solid tumor types, are advancing patient enrollment in the ongoing combination arms in MBC, and expect to initiate a Phase 1 study of OP-3136 in combination with Bayer’s darolutamide in metastatic castration-resistant prostate cancer by the end of this year.

Aspiring to transform the metastatic treatment paradigm is an ambitious endeavor that requires a resolute approach to developing better therapies and passionate colleagues dedicated to helping the patients we serve feel better, longer. Team Olema possesses a deep commitment to a shared purpose, the sustained pursuit of excellence, cultivating the courage required to advance our programs, the drive to succeed, and a collective capacity for adaptability through learning, growth, and evolution. We are a small group of nimble self-starters who bring consistency in our quest for the extraordinary every single day.

If you’re ready to be part of a tenacious, courageous, agile, and growing team, join us in making a profound impact, together – for our patients, for your career, and for what’s beyond.

### About the Role \>\>\> Executive Assistant, supporting Chief Financial Officer

We are seeking a highly motivated, resourceful, and experienced Executive Assistant to support our Chief Financial Officer (CFO) and approximately 4–6 senior leaders within the organization. This is a highly visible role that requires exceptional organizational skills, sound judgment, discretion, communication excellence, and the ability to effectively manage multiple priorities in a fast-paced, collaborative environment.

The Executive Assistant will provide seamless administrative support across the CFO leadership team, balancing the needs of multiple executives while helping ensure day-to-day operations run smoothly. You will manage communications and coordinate activities with internal and key external parties, including investors and board members. You will be a trusted partner to the CFO and leadership team, as well as a valued member of the broader Executive Assistant team, collaborating with colleagues to provide outstanding support across the organization.

If you are organized, proactive, collaborative, and energized by supporting executives in a dynamic environment, particularly within the biotechnology or pharmaceutical industry this is a unique opportunity to contribute to our mission to develop innovative medicines for breast cancer and beyond.

This role is based in our San Francisco, CA office and requires an on-site presence four days per week.

---
Data: alder (https://alderhq.app). Cite https://alderhq.app/jobs/greenhouse%3Aolema%3A6147547004 and the date you read it. Observed facts come from the employer's own listing; location reach, level, family and skills are inferences.